On Monday, Spanish dermatology group Almirall has released its full-year report for 2021. The headliner has been sales of psoriasis drug Ilumetri, an anti-IL-23 monoclonal antibody treatments for adults that was launched around a year ago. Ilumetri sales reached EUR 82m in 2021, corresponding to a growth of 87 percent, according to the report.
Other takeaways include a good sales performances from Almirall’s acne treatment Seysara and Klisyri, a treatment for the dermatological disease known as actinic keratosis (AK), which was approved in the US in 2020 and in Europe in the second half of 2021.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
CHMP to remove 100 generic medicines from market
Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.
New head of research at Astellas Gene Therapies: "Choosing the right indications is extra important"
Morten Søgaard is leaving Pfizer to join Astellas, where he will be in charge of 100 employees. Going from one of the world largest pharmaceutical firms to a considerably smaller one will be a challenge, he says.
Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
The German Minister for Health has revealed that the German state has ordered vaccines from Bavarian Nordic, as the country reports 5 cases of monkeypox.
Senior IT Network Engineer 
Analytical Senior Scientist 
Project Manager & Scrum Master 
Key Account Manager, Europe and Asia 
Clinical Project Manager 
Production Director 
Client Talent Acquisition Specialist 
(Senior) Drug Substance Specialist 
Nordic Medical Affairs Manager 
Clinical Trial Administrator 
Consultant Manager 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Senior Manager, Clinical Trial Budget 
Account Manager 
Senior Project Manager (GMP - Life Science) 
Industrial Designer- Design Engineer